10-112950748-G-GA
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BS1BS2
The NM_001367943.1(TCF7L2):c.1dup variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00253 in 1,533,132 control chromosomes in the GnomAD database, including 61 homozygotes. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.010 ( 24 hom., cov: 29)
Exomes 𝑓: 0.0017 ( 37 hom. )
Consequence
TCF7L2
NM_001367943.1 5_prime_UTR
NM_001367943.1 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.35
Genes affected
TCF7L2 (HGNC:11641): (transcription factor 7 like 2) This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes. Several transcript variants encoding multiple different isoforms have been found for this gene.[provided by RefSeq, Oct 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP6
Variant 10-112950748-G-GA is Benign according to our data. Variant chr10-112950748-G-GA is described in ClinVar as [Benign]. Clinvar id is 3257944.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0102 (1529/149880) while in subpopulation AFR AF= 0.0337 (1375/40810). AF 95% confidence interval is 0.0322. There are 24 homozygotes in gnomad4. There are 728 alleles in male gnomad4 subpopulation. Median coverage is 29. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1529 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TCF7L2 | NM_001367943.1 | c.1dup | 5_prime_UTR_variant | 1/15 | ENST00000355995.9 | ||
LOC124902502 | XR_007062291.1 | n.824_825insT | non_coding_transcript_exon_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TCF7L2 | ENST00000355995.9 | c.1dup | 5_prime_UTR_variant | 1/15 | 1 | NM_001367943.1 | |||
ENST00000369391.3 | n.357_358insT | non_coding_transcript_exon_variant | 2/2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0102 AC: 1528AN: 149780Hom.: 24 Cov.: 29
GnomAD3 genomes
AF:
AC:
1528
AN:
149780
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00364 AC: 447AN: 122762Hom.: 8 AF XY: 0.00296 AC XY: 194AN XY: 65550
GnomAD3 exomes
AF:
AC:
447
AN:
122762
Hom.:
AF XY:
AC XY:
194
AN XY:
65550
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00170 AC: 2348AN: 1383252Hom.: 37 Cov.: 32 AF XY: 0.00161 AC XY: 1096AN XY: 682506
GnomAD4 exome
AF:
AC:
2348
AN:
1383252
Hom.:
Cov.:
32
AF XY:
AC XY:
1096
AN XY:
682506
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0102 AC: 1529AN: 149880Hom.: 24 Cov.: 29 AF XY: 0.00995 AC XY: 728AN XY: 73134
GnomAD4 genome
AF:
AC:
1529
AN:
149880
Hom.:
Cov.:
29
AF XY:
AC XY:
728
AN XY:
73134
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Asia WGS
AF:
AC:
17
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1Other:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
TCF7L2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 31, 2024 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Neoplasm Other:1
-, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital | Jul 31, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at